Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Maria Dolores Cayero-Otero"'
Autor:
Mercedes Fernández-Arévalo, Josefa Alvarez-Fuentes, Maria Dolores Cayero-Otero, Maria João Gomes, Cláudia Martins, Bruno Sarmento, Lucía Martín-Banderas
Publikováno v:
Expert Opinion on Drug Delivery. 16:1413-1427
Background: Actually, no drugs provide therapeutic benefit to approximately one-third of depressed patients. Depression is predicted to become the first global disease by 2030. So, new therapeutic ...
Autor:
Raúl Ortiz, Laura Cabeza, Consolación Melguizo, José M. Baeyens, Gloria Perazzoli, Mazen M. El-Hammadi, Maria Dolores Cayero-Otero, Julia Jiménez-López, Lucía Martín-Banderas, Jose Prados
Publikováno v:
Pharmacological Research. 141:451-465
Paclitaxel (PTX), a chemotherapy agent widely used to treat lung cancer, is characterised by high toxicity, low bioavailability and the need to use of excipients with serious side effects that limit its use. Paclitaxel encapsulation into nanoparticle
Autor:
Irene García-Domínguez, Lucía Martín-Banderas, Mercedes Fernández-Arévalo, Ana M. Espinosa-Oliva, Rocío M. de Pablos, Maria Dolores Cayero-Otero, Antonio J. Herrera
Publikováno v:
Current Pharmaceutical Design. 24:1589-1616
Neurodegenerative diseases, like Alzheimer´s and Parkinson´s disease, are a group of disorders that have in common their increasingly high prevalence along with the shortage of effective treatments. In addition, the scientific community faces the c